Kirkland Advises Bristol Myers Squibb on $7 Billion Senior Notes Offering

Kirkland & Ellis advised Bristol Myers Squibb (NYSE: BMY) on its public offering of senior unsecured notes in a combined aggregate principal amount of $7 billion. The offering was conducted in connection with Bristol Myers Squibb’s previously announced acquisition of MyoKardia Inc.

Read the Bristol Myers Squibb press release

The Kirkland team was led by capital markets partner Sophia Hudson, and associates Asher Qazi and Enid Qin.